Drug
Cisatracurium Besylate NDC Codes
Cisatracurium Besylate is listed in the FDA NDC Directory as 38 finished products from 14 labelers.
Overview
Active ingredient: Cisatracurium besylate. Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Generic name
- Cisatracurium besylate
- Active ingredients
- Cisatracurium besylate
- Labelers
- Meitheal Pharmaceuticals Inc., Camber Pharmaceuticals Inc., Gland Pharma Limited, Hikma Pharmaceuticals USA Inc., Caplin Steriles Limited, Slate Run Pharmaceuticals, LLC, Hospira, Inc., Somerset Therapeutics, LLC, Sandoz Inc, Eugia US LLC
- Strengths
- Cisatracurium besylate 2 mg/mL; Cisatracurium besylate 10 mg/mL; Cisatracurium besylate 200 mg/20mL; Cisatracurium besylate 10 mg/5mL; Cisatracurium besylate 20 mg/10mL
- Dosage forms
- Injection, Injection, Solution
- Routes
- Intravenous
- Drug classes (FDA established)
- Nondepolarizing Neuromuscular Blocker
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 43
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | Injection, SolutionIntravenous | Avenacy, LLC | 83634-655 | 83634-0655-20 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-312 | 31722-0312-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-313 | 31722-0313-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-314 | 31722-0314-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-486 | 68083-0486-01 | — |
| Cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-487 | 68083-0487-01 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-488 | 68083-0488-01 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9397 | 00143-9397-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9160 | 00143-9160-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Caplin Steriles Limited | 65145-135 | 65145-0135-0165145-0135-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Caplin Steriles Limited | 65145-136 | 65145-0136-0165145-0136-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Caplin Steriles Limited | 65145-137 | 65145-0137-01 | — |
| Cisatracurium Besylate | Cisatracurium besylate 200 mg/20mL | InjectionIntravenous | Armas Pharmaceuticals | 72485-513 | 72485-0513-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-113 | 70436-0113-82 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9396 | 00143-9396-01 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-112 | 70436-0112-82 | — |
| Cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-114 | 70436-0114-82 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/5mL | InjectionIntravenous | Eugia US LLC | 55150-284 | 55150-0284-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 20 mg/10mL | InjectionIntravenous | Eugia US LLC | 55150-286 | 55150-0286-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1208 | 00409-1208-01 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1098 | 00409-1098-02 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Zydus Lifesciences Limited | 72785-0008 | 72785-0008-06 | — |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Zydus Lifesciences Limited | 72785-0009 | 72785-0009-06 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1532 | 70710-1532-06 | — |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1534 | 70710-1534-06 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1103 | 00409-1103-01 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/5mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-712 | 71288-0712-96 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/5mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-712 | 71288-0712-06 | — |
| Cisatracurium Besylate | Cisatracurium besylate 200 mg/20mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-713 | 71288-0713-96 | — |
| Cisatracurium Besylate | Cisatracurium besylate 200 mg/20mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-713 | 71288-0713-21 | — |
| Cisatracurium Besylate | Cisatracurium besylate 20 mg/10mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-714 | 71288-0714-96 | — |
| Cisatracurium Besylate | Cisatracurium besylate 20 mg/10mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-714 | 71288-0714-11 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Somerset Therapeutics, LLC | 70069-161 | 70069-0161-0170069-0161-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Somerset Therapeutics, LLC | 70069-141 | 70069-0141-0170069-0141-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Somerset Therapeutics, LLC | 70069-151 | 70069-0151-0170069-0151-10 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Sandoz Inc | 0781-3150 | 00781-3150-95 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Sandoz Inc | 0781-3152 | 00781-3152-95 | — |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Sandoz Inc | 0781-3153 | 00781-3153-95 | — |
Cisatracurium Besylate: common questions
- What is the NDC for Cisatracurium Besylate?
- Cisatracurium Besylate has 38 product NDCs, one for each strength, dosage form and labeler; each product NDC then has one package NDC per package size. Pick the row for your product above to see its package NDCs.
- Is there a J-code for Cisatracurium Besylate?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.